Calidi Biotherapeutics, Inc.
Asset & Liabilities Breakdown
Asset Breakdown FY2024
Total Assets: $14.2M
Liabilities Breakdown FY2024
Total Liabilities: $12.2M
Asset Breakdown
Total Assets: $14.2M
| Line Item | Value | % of Total |
|---|---|---|
| Cash & Equivalents | $9.6M | 67.7% |
| Accounts Receivable | $0 | 0.0% |
| Inventory | $0 | 0.0% |
| Property, Plant & Equipment | $869.0K | 6.1% |
| Goodwill | $0 | 0.0% |
| Intangible Assets | $0 | 0.0% |
| Other Assets | $3.7M | 26.2% |
Liabilities Breakdown
Total Liabilities: $12.2M
| Line Item | Value | % of Total |
|---|---|---|
| Accounts Payable | $0 | 0.0% |
| Long-Term Debt | $600.0K | 4.9% |
| Other Liabilities | $11.6M | 95.1% |